Milestone Scientific to Present at The Noble Capital Markets Eighteenth Annual Investor Conference on April 21st
April 14 2022 - 11:00AM
Milestone Scientific Inc. (NYSE:MLSS), a leading
developer of computerized drug delivery instruments, that provide
painless and precise injections, today announced that Arjan
Haverhals, President and CEO of Milestone Scientific, will present
at the Noble Capital Markets Eighteenth Annual Investor Conference
being held on April 20-21, 2022 at the Hard Rock Hotel & Casino
in Hollywood, Florida.
Mr. Haverhals will present on Thursday, April 21st
at 11:30 am Eastern Time, in Seminole Ballroom D. Investors
interested in meeting with management can meet at the breakout
sessions on Wednesday, April 20th at 12:15 pm Eastern Time at Table
10 and at 3:15 pm Eastern Time at Table 6.
A high-definition, video webcast of the
presentation will be available the following day on the Company's
website https://www.milestonescientific.com/, and as part of a
complete catalog of presentations available at Noble Capital
Markets’ Conference website: www.nobleconference.com and on
Channelchek www.channelchek.com the investor portal created by
Noble. The webcast will be archived on the company's website, the
NobleCon website and on Channelchek.com for 90 days following the
event.
About Noble Capital Markets,
Inc.Noble Capital Markets (“Noble”) is a research driven
investment bank that has supported small & microcap companies
since 1984. As a FINRA and SEC licensed broker dealer Noble
provides institutional-quality equity research, merchant and
investment banking, and order execution services. In 2005, Noble
established NobleCon, an investor conference that has grown
substantially over the last decade. Noble launched
www.channelchek.com in 2018 - an investor community dedicated
exclusively to public small and micro-cap companies and their
industries. Channelchek is the first service to offer
institutional-quality research to the public, for FREE at every
level without a subscription. More than 6,000 public emerging
growth companies are listed on the site, with growing content
including research, webcasts, podcasts, and balanced news.
About Milestone Scientific
Inc.Milestone Scientific Inc. (MLSS), a technology focused
medical research and development company that patents, designs and
develops innovative injection technologies and instruments for
medical, dental and cosmetic applications. Milestone Scientific’s
computer-controlled systems are designed to make injections
precise, efficient and increase the overall patient comfort and
safety. Their proprietary DPS Dynamic Pressure Sensing Technology®
instruments is the platform to advance the development of
next-generation devices, regulating flow rate and monitoring
pressure from the tip of the needle, through platform extensions of
subcutaneous drug delivery, including local anesthetic. To learn
more, view the MLSS brand video or visit
milestonescientific.com.
Safe Harbor StatementThis press
release contains forward-looking statements regarding the timing
and financial impact of Milestone's ability to implement its
business plan, expected revenues, timing of regulatory approvals
and future success. These statements involve a number of risks and
uncertainties and are based on assumptions involving judgments with
respect to future economic, competitive and market conditions,
future business decisions and regulatory developments, all of which
are difficult or impossible to predict accurately and many of which
are beyond Milestone's control. Some of the important factors that
could cause actual results to differ materially from those
indicated by the forward-looking statements are general economic
conditions, failure to achieve expected revenue growth, changes in
our operating expenses, adverse patent rulings, FDA or legal
developments, competitive pressures, changes in customer and market
requirements and standards, and the risk factors detailed from time
to time in Milestone's periodic filings with the Securities and
Exchange Commission, including without limitation, Milestone's
Annual Report for the year ended December 31, 2020. The
forward-looking statements in this press release are based upon
management's reasonable belief as of the date hereof. Milestone
undertakes no obligation to revise or update publicly any
forward-looking statements for any reason.
Contact: David Waldman or Natalya
RudmanCrescendo Communications, LLCEmail: mlss@crescendo-ir.comTel:
212-671-1020
Milestone Scientific (AMEX:MLSS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Milestone Scientific (AMEX:MLSS)
Historical Stock Chart
From Apr 2023 to Apr 2024